These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 1339738
1. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer]. Yu BM. Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738 [Abstract] [Full Text] [Related]
2. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]. Lorenz M, Happ J, Hottenrott C, Maul FD, Baum RP, Hör G, Encke A. Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133 [Abstract] [Full Text] [Related]
3. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse. Nicolini A, Caciagli M, Zampieri F, Ciampalini G, Carpi A, Spisni R, Colizzi C. Cancer Detect Prev; 1995 Feb; 19(2):183-95. PubMed ID: 7750106 [Abstract] [Full Text] [Related]
7. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer. Carpelan-Holmström MA, Haglund CH, Järvinen HJ, Roberts PJ. Anticancer Res; 1996 Feb; 16(2):981-6. PubMed ID: 8687164 [Abstract] [Full Text] [Related]
10. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers]. Terabe K, Ichihashi H, Kamei H, Kondo T. Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454 [Abstract] [Full Text] [Related]
11. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9. Quentmeier A, Schlag P, Geisen HP, Schmidt-Gayk H. Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158 [Abstract] [Full Text] [Related]
12. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum]. Hamazoe R, Yoshioka H, Furumoto T, Kanayama H, Shimizu N, Maeta M, Koga S. Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968 [Abstract] [Full Text] [Related]
13. [Clinical evaluation of CEA in colorectal carcinoma]. Shimoyama T, Fukuda Y, Itoh S, Shimizu T, Kawaguchi A, Mori M, Ishii T, Miura T, Tomita M. Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618 [Abstract] [Full Text] [Related]
14. [Clinical applications of the carcinoembryonic antigen (CEA) determination in colorectal cancer (observations of 119 cases)]. Sivelli R, Farinon AM, Chiampo L. Chir Ital; 1980 Oct; 32(5):946-63. PubMed ID: 6166402 [Abstract] [Full Text] [Related]
16. Clinical evaluation of M43: a novel cancer-associated mucin epitope. Goodgame R, Kiefe C, Rose E, Sutton F, Brown J, Alpert E. Cancer Res; 1993 Jun 15; 53(12):2803-9. PubMed ID: 7684947 [Abstract] [Full Text] [Related]
17. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis]. Heptner G, Domschke S, Krapf F, Schneider MU, Iro H, Domschke W. Dtsch Med Wochenschr; 1984 Aug 31; 109(35):1309-12. PubMed ID: 6590287 [Abstract] [Full Text] [Related]
18. CEA radioimmunoassay. Clinical applications in colorectal cancer. Huyghe J. Acta Chir Belg; 1983 Aug 31; 83(2):77-88. PubMed ID: 6858539 [Abstract] [Full Text] [Related]
19. [Determination of carcinoembryonic and carbohydrate antigens in the diagnosis of recurrences and metastases of rectal cancer]. Ozhiganov EL, Kuznetsova LF. Med Radiol (Mosk); 1986 Aug 31; 31(8):40-4. PubMed ID: 3462448 [Abstract] [Full Text] [Related]
20. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer. Onetto M, Paganuzzi M, Secco GB, Fardelli R, Santi F, Rovida S, Ferrara GB. Biomed Pharmacother; 1985 Aug 31; 39(7):392-5. PubMed ID: 3830268 [Abstract] [Full Text] [Related] Page: [Next] [New Search]